EUVIMEDEUVIMED entdecken
Crossref

Enhanced neurobiological biomarker differentiation for attention-deficit/hyperactivity disorder through a risk-informed design

Igor Duarte, Mauricio Scopel Hoffmann, Giovanni A Salum, Douglas Teixeira Leffa, Sintia Belangero, Marcos Santoro, Vanessa Kiyomi Ota, Lucas Toshio Ito, Pedro M Pan, Luis C Farhat, Aja Louise Murray, Euripedes C Miguel und 3 weitere

European Child & Adolescent Psychiatry · 2025

DOI: 10.1007/s00787-024-02622-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Child & Adolescent Psychiatry, 2025. Verfasst von Igor Duarte und 14 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Executive Function, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Translation of biomarkers to clinical practice is hindered by the significant overlap in neurobiological measures between ADHD cases and controls. A risk-informed design can enhance the utility and validation of ADHD biomarkers by highlighting differences between individuals with ADHD and those without at differential risk. Participants were 2511 children and adolescents (aged 6 to 14 years) from the Brazilian High Risk Cohort for Mental Conditions. We calculated risk for ADHD among unaffected individuals using a multivariable clinical and sociodemographic risk model. We compared measures of three proposed ADHD biomarkers (polygenic scores, subcortical volumes, and executive function) between participants with vs. without ADHD, and ADHD vs. without ADHD with a high- vs. low-risk loading for ADHD. Compared to the unaffected group, children and adolescents with ADHD had higher ADHD polygenic scores (cohen's d = 0.17), smaller subcortical volumes (d = - 0.25), and poorer executive function (d = - 0.22). Separating the unaffected group into low- and high-risk subgroups revealed more pronounced differences (Cohen's d = 0.20 to 0.60) and nearly doubled the overlap-free area for these three neurobiological measures between the low-risk group and the other two groups. Upon adjustment for the number of ADHD symptoms, simple ADHD vs. without ADHD differences vanished, while the risk-informed analyses remained significant. Here, we demonstrate that a risk-based design increases effect sizes when comparing candidate biomarkers for ADHD. Our study provides a model that may hold promise for evaluating similar contrasts in other mental disorders and samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityExecutive FunctionBrainHumansAdolescentChildMaleFemaleBiomarkersMagnetic Resonance ImagingBrazil

Stichwörter der Autor:innen

Attention-deficit/hyperactivity disorder (ADHD)Machine learningMultivariableNeurobiological biomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Attention-Deficit/Hyperactivity Disorders Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • National Center for Research and Innovation in Mental Health (CISM), São Paulo, Brazil.
  • Department of Psychiatry, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil.
  • Mental Health Epidemiology Group (MHEG), Universidade Federal de Santa Maria, Santa Maria, Brazil.
  • Care Policy and Evaluation Centre, London School of Economics and Political Science, London, UK.

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Duarte, I., Hoffmann, M. S., Salum, G. A., Leffa, D. T., Belangero, S., Santoro, M., Ota, V. K., Ito, L. T., Pan, P. M., Farhat, L. C., Murray, A. L., Miguel, E. C., Kieling, C., Rohde, L. A., & Caye, A. (2025). Enhanced neurobiological biomarker differentiation for attention-deficit/hyperactivity disorder through a risk-informed design. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-024-02622-4

Vancouver

Duarte I, Hoffmann MS, Salum GA, Leffa DT, Belangero S, Santoro M, et al. Enhanced neurobiological biomarker differentiation for attention-deficit/hyperactivity disorder through a risk-informed design. European Child & Adolescent Psychiatry. 2025. doi:10.1007/s00787-024-02622-4

BibTeX
@article{Duarte2025,
  author = {Duarte, Igor and Hoffmann, Mauricio Scopel and Salum, Giovanni A and Leffa, Douglas Teixeira and Belangero, Sintia and Santoro, Marcos and Ota, Vanessa Kiyomi and Ito, Lucas Toshio and Pan, Pedro M and Farhat, Luis C and Murray, Aja Louise and Miguel, Euripedes C and Kieling, Christian and Rohde, Luis Augusto and Caye, Arthur},
  title = {Enhanced neurobiological biomarker differentiation for attention-deficit/hyperactivity disorder through a risk-informed design},
  journal = {European Child & Adolescent Psychiatry},
  year = {2025},
  doi = {10.1007/s00787-024-02622-4}
}
Kostenlos starten →